249 related articles for article (PubMed ID: 34804119)
1. Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review.
Osuna-Marco MP; López-Barahona M; López-Ibor B; Tejera ÁM
Front Genet; 2021; 12():749480. PubMed ID: 34804119
[TBL] [Abstract][Full Text] [Related]
2. [Trisomy 21 and cancers].
Ayed W; Gouas L; Penault-Llorca F; Amouri A; Tchirkov A; Vago P
Morphologie; 2012 Oct; 96(314-315):57-66. PubMed ID: 23141635
[TBL] [Abstract][Full Text] [Related]
3. A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.
Forés-Martos J; Cervera-Vidal R; Chirivella E; Ramos-Jarero A; Climent J
Front Physiol; 2015; 6():10. PubMed ID: 25698970
[TBL] [Abstract][Full Text] [Related]
4. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
6. A tumor profile in Patau syndrome (trisomy 13).
Satgé D; Nishi M; Sirvent N; Vekemans M; Chenard MP; Barnes A
Am J Med Genet A; 2017 Aug; 173(8):2088-2096. PubMed ID: 28544599
[TBL] [Abstract][Full Text] [Related]
7. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System.
Satgé D; Seidel MG
Front Immunol; 2018; 9():3058. PubMed ID: 30631328
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis in the examination of solid tumors in children.
Mertens F; Mandahl N; Mitelman F; Heim S
Pediatr Hematol Oncol; 1994; 11(4):361-77. PubMed ID: 7947009
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Sas V; Pasca S; Jurj A; Pop L; Muramatsu H; Ono H; Dima D; Teodorescu P; Iluta S; Turcas C; Onaciu A; Munteanu R; Zimta AA; Blag C; Popa G; von Gamm EDA; Arghirescu S; Serban M; Man S; Marian M; Petrushev B; Berce C; Colita A; Zdrenghea M; Kojima S; Gulei D; Takahashi Y; Tomuleasa C
Cell Physiol Biochem; 2020 Oct; 54(5):994-1012. PubMed ID: 33006449
[TBL] [Abstract][Full Text] [Related]
10. Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors.
Gardner HA; Gallie BL; Knight LA; Phillips RA
Cancer Genet Cytogenet; 1982 Jul; 6(3):201-11. PubMed ID: 7116318
[TBL] [Abstract][Full Text] [Related]
11. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
12. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
[TBL] [Abstract][Full Text] [Related]
13. A tumor profile in Edwards syndrome (trisomy 18).
Satgé D; Nishi M; Sirvent N; Vekemans M
Am J Med Genet C Semin Med Genet; 2016 Sep; 172(3):296-306. PubMed ID: 27474103
[TBL] [Abstract][Full Text] [Related]
14. Solid malignancies in individuals with Down syndrome: a case presentation and literature review.
Bratman SV; Horst KC; Carlson RW; Kapp DS
J Natl Compr Canc Netw; 2014 Nov; 12(11):1537-45. PubMed ID: 25361800
[TBL] [Abstract][Full Text] [Related]
15. [Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?].
Martel-Billard C; Cordier C; Tomasetto C; Jégu J; Mathelin C
Gynecol Obstet Fertil; 2016 Apr; 44(4):211-7. PubMed ID: 27032759
[TBL] [Abstract][Full Text] [Related]
16. Meningioma in Down Syndrome.
Yamamoto T; Shinojima N; Todaka T; Nishikawa S; Yano S; Kuratsu J
World Neurosurg; 2015 Sep; 84(3):866.e1-6. PubMed ID: 25862935
[TBL] [Abstract][Full Text] [Related]
17. First Reported Case of Atypical Meningioma in an Individual with Down Syndrome.
Vanderschelden R; Golshani K; Evans MG
Case Rep Neurol; 2022; 14(1):191-196. PubMed ID: 35611359
[TBL] [Abstract][Full Text] [Related]
18. Pattern of malignant disorders in individuals with Down's syndrome.
Hasle H
Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
[TBL] [Abstract][Full Text] [Related]
19. A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.
Satgé D; Stiller CA; Rutkowski S; von Bueren AO; Lacour B; Sommelet D; Nishi M; Massimino M; Garré ML; Moreno F; Hasle H; Jakab Z; Greenberg M; von der Weid N; Kuehni C; Zurriaga O; Vicente ML; Peris-Bonet R; Benesch M; Vekemans M; Sullivan SG; Rickert C
J Neurooncol; 2013 Mar; 112(1):107-14. PubMed ID: 23307327
[TBL] [Abstract][Full Text] [Related]
20. A tumor profile in Down syndrome.
Satgé D; Sommelet D; Geneix A; Nishi M; Malet P; Vekemans M
Am J Med Genet; 1998 Jul; 78(3):207-16. PubMed ID: 9677053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
